Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | STAT1 | P42224 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9430673 | 0.97 | STAT3 (0.42) | STAT3STAT1 | |
| SCHEMBL6517023 | 0.97 | STAT3 (0.42) | STAT3STAT1 | |
| SCHEMBL30821407 | 0.97 | STAT3 (0.42) | STAT3STAT1 | |
| SCHEMBL29430977 | 0.97 | STAT3 (0.42) | STAT3STAT1 | |
| SCHEMBL6744970 | 0.97 | STAT3 (0.42) | STAT3STAT1 | |
| SCHEMBL15809 | 0.97 | STAT3 (0.42) | STAT3STAT1 | |
| SCHEMBL21729 | 0.95 | STAT3 (0.41) | STAT3STAT1 | |
| SCHEMBL705768 | 0.95 | STAT3 (0.41) | STAT3STAT1 | |
| SCHEMBL9717057 | 0.95 | STAT3 (0.41) | STAT3STAT1 | |
| SCHEMBL1603039 | 0.95 | STAT3 (0.41) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635517-A1 | METAL-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF MAKING AND USING THEREOF | Laboratory for Synthetic Chemistry and Chemical Biology Limited (HK) | 2025-10-22 | — | — | EP | claimed |
| CN-119504769-A | Antibody-coupled gold (III) porphyrin medicine targeting HER2, synthesis and tumor treatment application thereof | 高博药业有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-116689030-A | MB@Apt-COF composite material and preparation method and application thereof | 河北科技大学 | 2023-09-05 | — | — | CN | claimed |
| CN-108779124-B | Gold porphyrin-PEG conjugates and methods of use | 香港大学 | 2022-03-01 | — | — | CN | claimed |
| CN-105597098-B | A kind of bonded gold nanorods compound of Herceptin, preparation method and the application in HER2 positive breast cancer diagnosis and treatment | 哈尔滨医科大学 | 2019-05-31 | — | — | CN | claimed |
| CN-109464986-A | A kind of preparation and application of the nanocomposite based on porphyrin metal organic frame and ternary sulfide | 西北师范大学 | 2019-03-15 | — | — | CN | claimed |
| CN-107064277-B | A kind of preparation method and application of electrochemical sensor | 湖北民族学院 | 2018-03-20 | — | — | CN | claimed |
| CN-107064277-A | A kind of preparation method and application of electrochemical sensor | 湖北民族学院 | 2017-08-18 | — | — | CN | claimed |
| CN-105597098-A | Trastuzumab bond-linking gold nanorod compound, preparation method and application thereof in diagnosis and treatment of HER2 positive breast cancer | UNIV HARBIN MEDICAL | 2016-05-25 | — | — | CN | claimed |
| CN-102167704-B | Water-soluble porphyrin gold (III) anticancer compounds and preparation method thereof | UNIV YANGZHOU | 2014-05-14 | — | — | CN | claimed |
| CN-102268003-B | Unsymmetrical poly-substituted porphyrin gold (III) type anticancer compound and preparation method thereof | UNIV YANGZHOU | 2013-10-30 | — | — | CN | claimed |
| CN-102180883-B | Substituted porphyrin gold (III) compounds with anticancer activity and preparation method thereof | UNIV YANGZHOU | 2013-04-17 | — | — | CN | claimed |
| CN-102268003-A | Unsymmetrical poly-substituted porphyrin gold (III) type anticancer compound and preparation method thereof | — | 2011-12-07 | — | — | CN | claimed |
| CN-102180883-A | Substituted porphyrin gold (III) compounds with anticancer activity and preparation method thereof | UNIV YANGZHOU | 2011-09-14 | — | — | CN | claimed |
| CN-102167704-A | Water-soluble porphyrin gold (III) anticancer compounds and preparation method thereof | UNIV YANGZHOU | 2011-08-31 | — | — | CN | claimed |
| US-6727358-B2 | NONLINEAR OPTICAL OR ELECTRICAL RESPONSE | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2004-04-27 | — | — | US | claimed |
| US-20030187251-A1 | Porphyrin array having imidazolyl porphyrin metal complex as structural unit thereof and method of producing the same | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2003-10-02 | — | — | US | claimed |
| EP-4635517-A1 | METAL-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF MAKING AND USING THEREOF | Laboratory for Synthetic Chemistry and Chemical Biology Limited (HK) | 2025-10-22 | — | — | EP | disclosed |
| WO-2004024146-A1 | METHODS FOR USING GOLD (III) COMPLEXES AS ANTI-TUMOR AND ANTI-HIV AGENTS | THE UNIVERSITY OF HONG KONG (CN) | 2004-03-25 | — | — | WO | disclosed |
| US-20030187251-A1 | Porphyrin array having imidazolyl porphyrin metal complex as structural unit thereof and method of producing the same | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2003-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187251-A1 | Porphyrin array having imidazolyl porphyrin metal complex as structural unit thereof and method of producing the same | MT-CO1, CYC1, AP1M1 | STAT3 2712/4885STAT1 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.